Rising use of illicit drugs, increasing number of drug screening labs, rising demand for presumptive tests, and increasing adoption of drug screening tests at workplace are key factors driving market growth.
Rising use of illicit drugs, increasing number of drug screening labs, rising demand for presumptive tests, and increasing adoption of drug screening tests at workplace are key factors driving market growth
The global specimen validity testing market size is expected to reach USD 2.10 Billion in 2028 and register a CAGR of 6.6% during the forecast period, according to the latest report by Reports and Data. Rising use of therapeutics, abuse, and prescription diversion, rapid adoption of urine drug testing at workplace, growing population of drug abusers, and increasing consumption of illicit drugs among the younger generation are some key factors expected to drive market revenue growth over the forecast period. Presence of stringent regulations and laws that necessitate drug screening and increasing efforts by governments to regulate and control drug abuse are other factors expected to drive market revenue growth going ahead.
Specimen Validity Testing (SVT) is generally performed on urine specimens and is an integral part of drug screening tests as it provides crucial data to clinicians about accuracy and reliability of drug test results. Specimen validity testing can detect adulteration, substitution, or dilution by measuring pH, specific gravity, creatinine, and oxidizing adulterant. Testing plays a crucial role in the healthcare sector as it allows clinicians to determine patient behavior, medicine adherence, and honesty in communication. Various techniques, instruments, and tools have been developed to monitor adherence by combining urine drug testing with prescription monitoring programs and other screening tests. This is expected to drive revenue growth of the market over the forecast period.
Increasing initiatives by governments to encourage drug screening at workplaces, law enforcement agencies, and other organizations is also expected to drive market growth going ahead. Rising awareness regarding specimen validity testing, increasing incidence of drug abuse and overdose, and growing investment in research and development to develop efficient and fast point-of-care testing products is expected to contribute significantly to revenue growth of the market over the forecast period. However, availability of alternative and rapid screening tests and lengthy regulatory approval processes are expected to restrain market growth to a certain extent over the forecast period.
Access Free sample PDF Copy of the Report @ https://www.reportsanddata.com/sample-enquiry-form/4098
Some Key Highlights from the Report:
- Reagents, calibrators, and controls segment is expected to dominate other product segments in terms of revenue during the forecast period owing to increasing demand for reagents in drug screening laboratories and growing global demand for rapid screening kits.
- Rapid/POC testing segment is expected to account for largest revenue share in the global market owing to increasing demand for point-of-care testing products due to benefits such as rapid and accurate results and simultaneous detection of multiple drugs in the specimen.
- Increasing incidence of workplace substance abuse, increasing awareness about drug screening tests, growing need to enhance employee safety, and large number of organizations mandating workplace drug screening are key factors contributing to revenue growth of workplace segment.
- Asia Pacific is expected to register robust revenue CAGR during the forecast period owing to rising levels of disposable income, increasing incidence of methamphetamine and ketamine abuse, increasing R&D investment and expenditure, and development of modern healthcare and clinical facilities in the region.
- Prominent companies operating in the market include Thermo Fisher Scientific, Inc., Sciteck, American Bio Medica Corporation, Alere, Express Diagnostics, Premier Biotech, LabCorp., Quest Diagnostics, Alere Toxicology, ACM Global Laboratories, Clinical Reference Laboratory (CRL), SureHire, and CannAmm, among others.
- In April 2020, Nona Scientific, which is a toxicology laboratory located in the United States, introduced a new specimen validity test, called the NonaClear 2.0 which can precisely and timely screen and detect synthetic urine and determine if the specimen has been manipulated by salting, oxidants, and detox drinks, among others.
Buy now your Exclusive copy of Report @ https://www.reportsanddata.com/checkout-form/4098
For the purpose of this report, Reports and Data has segmented the global specimen validity testing market based on product & services, type, end-use, and region:
Product & Services Outlook (Revenue, USD Billion; 2018-2028)
- Products
- Reagents, Calibrators, & Controls
- Assay Kits
- Disposable
- Services
Type Outlook (Revenue, USD Billion; 2018-2028)
- Laboratory Testing
- Rapid/POC Testing
End-use Outlook (Revenue, USD Billion; 2018-2028)
- Workplaces
- Drug Screening Laboratories
- Law Enforcement Agencies
- Pain Management Centres
- Drug Rehabilitation Centres
- Others
Request for Custom Research @ https://www.reportsanddata.com/request-customization-form/4098
Regional Outlook (Revenue, USD Billion; 2018-2028)
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- U.K.
- Italy
- France
- BENELUX
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of APAC
- Latin America
- Brazil
- Rest of LATAM
- Middle East & Africa
- Saudi Arabia
- U.A.E.
- South Africa
- Rest of MEA
Explore Reports and Data’s Prime Analysis of the global Pharmaceutical & Healthcare Industry:
Biobanks Market By Type (Disease-Oriented Biobanks, Population-Based Biobanks), By Storage Type (Manual Storage, Automated Storage), By Product, By Specimen Type And By Application, Forecasts To 2027
Biopreservation Market Trends, Growth & Analysis, By Type (Biospecimen Equipment, Biopreservation Media, Cryogenic Storage Systems, Freezers, Refrigerators, Thawing Equipment), By Biospecimen, By Application, And By End Users, And Segment Forecasts To 2027
Predictive Genetic Testing & Consumer/Wellness Genomics Market Size, Share & Analysis, By Type (On-Premise, Cloud Based), By Application (Predictive Genetic Testing & Consumer Genomics, Wellness Genomics), By Setting Type (Clinic, Direct To Consumer, Hospital), And By Region Forecast To 2028
About Reports and Data
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise.
Contact Us:
John W
Head of Business Development
Reports and Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com
Read Full Press Release: https://www.reportsanddata.com/press-release/global-specimen-validity-testing-market